Aetna to pull back further from Obamacare exchanges

Tammy Harvey
May 4, 2017

Finally, Oppenheimer Holdings Inc. restated an outperform rating on shares of Aetna in a report on Friday, March 31st. Alpha One also assigned media stories about the company an impact score of 66 out of 100, meaning that recent press coverage is likely to have an impact on the company's share price in the immediate future. Vetr upgraded shares of Aetna from a buy rating to a strong-buy rating and set a $133.56 target price on the stock in a report on Monday, January 23rd. (AET) may be overvalued, however, this can also depend upon the situation of the market; if the market is strong then it could suggest that Aetna Inc.

There are 6 hold ratings, 11 buy ratings on the stock. Piper Jaffray Companies initiated coverage on Aetna in a research note on Wednesday, January 4th.

Aetna said it expects 2017 losses on its individual business will amount to roughly half its loss a year ago, which was $450 million.

The target price for Aetna Inc. (NYSE:AET) have shifted north recently, touching a new 52-week high.

Beta factor of the stock stands at 0.66. Over the last five trading sessions, the stock has moved 3.80%.

Despite the challenges, Aetna's adjusted earnings rose 14 percent to $939 million from $821 million in the year-ago period. Earnings, adjusted for one-time gains and costs, were $2.71 per share.


Aetna Inc.'s ROA is now valued at 3.40% * with a ROI value of 7.40% *.

Analysts expect, on average, earnings of $8.88 per share for 2017, according to FactSet. During the same period in the previous year, the business earned $2.30 EPS. Aetna posted operating revenues of $15.2 billion, where as our consensus estimate of $15.47 billion. Investors of record on Thursday, April 13th were paid a $0.50 dividend. The third largest holder is State Street Corp, which now holds $2.9 billion worth of this stock and that ownership represents almost 6.6% of its market capitalization.

Aetna shares were up 1.6 percent, or $2.21, at $139.02. The ex-dividend date of this dividend was Tuesday, April 11th. For the past month, Aetna Inc.'s stock has been 9.33%, 17.57% for the last quarter, 30.12% for the past six months and 23.27% for the past 52 weeks. The stock was sold at an average price of $131.98, for a total transaction of $871,991.86. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Vice President, CFO GUERTIN SHAWN M has sold 29,602 shares of Aetna Inc. The stock was sold at an average price of $129.35, for a total transaction of $3,829,018.70.

Shares of Humana climbed $1.78 to $227.38 in pre-market trading Wednesday, after the company detailed its quarterly performance. The disclosure for this sale can be found here. Arizona State Retirement System now owns 95,234 shares of the company's stock worth $10,995,000 after buying an additional 500 shares during the last quarter.

On 5/20/2016 Aetna announced a quarterly dividend of $0.25 0.91% with an ex dividend date of 7/12/2016 which will be payable on 7/29/2016. First Manhattan Co. now owns 4,300 shares of the company's stock worth $496,000 after buying an additional 100 shares in the last quarter.

EVP, Operations & Technology, McCarthy Margaret M, sold 7,930 common shares of Aetna Inc. Hedge funds and other institutional investors own 88.40% of the company's stock.

Other reports by Ligue1talk

Discuss This Article

FOLLOW OUR NEWSPAPER